/
Longitudinal Impact of CT-defined leaflet thrombosis after transcatheter aortic valve replacement
Computed tomography (CT) has been shown to be an accurate method to diagnose leaflet thrombosis (LT) following transcatheter aortic valve replacement (TAVR). Majority of patients diagnosed with this condition are asymptomatic without valve dysfunction or cerebrovascular events. Observational data at one-year follow-up has been conflicting but some studies have demonstrated that CT-defined LT may lead to dysfunction of the valve, repeat valve replacement and cerebrovascular events. Previous studies have been limited by short duration and incomplete follow-up.
Dr Hashrul Rashid's study will prospectively evaluate patients for LT with CT within 6 weeks following the TAVR procedure. One component of the study involves evaluating the impact of this condition on clinical outcomes and valvular function, with echocardiogram at one month and one year (annually thereafter, where possible). Another substudy will perform serial CT (one month and one year then annually where possible) to determine predictors of valve failure by quantifying the threshold of clot burden.
Finding ways to detect leaflet thrombosis (LT) earlier to improve health outcomes.
Computed tomography (CT) is highly accurate in detecting small sized clots on valve leaflets but it is a limited resource and it comes with the risk of contrast-related kidney impairment and radiation exposure. This research aims to predict which patients may develop valve clots following TAVR.
Immersive transcatheter aortic valve replacement
Last updated30 March 2022